Multi-modality imaging for assessment of myocardial viability?

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation (2005) 18.90

The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med (2000) 13.25

Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J (2005) 7.75

Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet (2003) 5.33

Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol (2002) 4.11

Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomography. Circulation (2002) 2.43

Impact of viability and scar tissue on response to cardiac resynchronization therapy in ischaemic heart failure patients. Eur Heart J (2006) 1.83

Imaging techniques for the assessment of myocardial hibernation. Report of a Study Group of the European Society of Cardiology. Eur Heart J (2004) 1.77

Sensitivity, specificity, and predictive accuracies of non-invasive tests, singly and in combination, for diagnosis of hibernating myocardium. Eur Heart J (2000) 1.54

Nitrate-enhanced thallium 201 single-photon emission computed tomography imaging in hibernating myocardium. Am Heart J (1999) 1.45

Time course of functional recovery of stunned and hibernating segments after surgical revascularization. Circulation (2001) 1.44

Sequential (201)Tl imaging and dobutamine echocardiography to enhance accuracy of predicting improved left ventricular ejection fraction after revascularization. J Nucl Med (2002) 1.42

Myocardial viability by contrast-enhanced cardiovascular magnetic resonance in patients with coronary artery disease: comparison with gated single-photon emission tomography and FDG position emission tomography. Int J Cardiovasc Imaging (2007) 1.39

Prognostic value of myocardial ischemia and viability in patients with chronic left ventricular ischemic dysfunction. Circulation (1999) 1.14

Failure to improve left ventricular function after coronary revascularization for ischemic cardiomyopathy is not associated with worse outcome. Circulation (1999) 1.10

Residual 201Tl activity in irreversible defects as a marker of myocardial viability. Clinicopathological study. Circulation (1995) 0.86

Baseline/postnitrate tetrofosmin SPECT for myocardial viability assessment in patients with postischemic severe left ventricular dysfunction: new evidence from MRI. J Nucl Med (2005) 0.80

Sestamibi SPECT in the detection of myocardial viability in patients with chronic ischemic left ventricular dysfunction: comparison between visual and quantitative analysis. J Nucl Cardiol (2001) 0.77

Comparison of 64-slice cardiac computed tomography with myocardial perfusion scintigraphy for assessment of global and regional myocardial function and infarction in patients with low to intermediate likelihood of coronary artery disease. J Nucl Cardiol (2008) 1.51

Sixty-four-slice computed tomography coronary angiography compared with myocardial perfusion scintigraphy for the diagnosis of functionally significant coronary stenoses in patients with a low to intermediate likelihood of coronary artery disease. J Nucl Cardiol (2008) 1.42

Clinical value, cost-effectiveness, and safety of myocardial perfusion scintigraphy: a position statement. Eur Heart J (2008) 0.99

Pilot clinical study of an endoscopic, removable duodenal-jejunal bypass liner for the treatment of type 2 diabetes. Diabetes Technol Ther (2009) 0.97

[A proposal of guidelines for surgical management of obesity]. Rev Med Chil (2005) 0.90

Combined coronary and perfusion cardiovascular magnetic resonance for the assessment of coronary artery stenosis. J Cardiovasc Magn Reson (2004) 0.84

Procedure guidelines for radionuclide myocardial perfusion imaging with single-photon emission computed tomography. Nucl Med Commun (2013) 0.79

Images in cardiovascular medicine. The complex pathophysiology of acute myocardial infarction imaged by cardiovascular magnetic resonance: infarction, edema, microvascular obstruction, and inducible ischemia. Circulation (2008) 0.78

Myocardial perfusion scintigraphy: technical innovations and evolving clinical applications. Heart (2011) 0.78

[Predictive accuracy of body mass index in estimating body fatness measured by bioelectrical impedance]. Arch Latinoam Nutr (2004) 0.77

Myocardial perfusion scintigraphy: an important step between clinical assessment and coronary angiography in patients with stable chest pain. Eur Heart J (2005) 0.77

[Resting energy expenditure in obese and non-obese Chilean subjects: comparison with predictive equations for the Chilean population]. Rev Med Chil (2002) 0.76

The prognostic value of myocardial perfusion imaging in patients with suspected or known coronary artery disease. Nucl Med Commun (2004) 0.75

Ciprofibrate therapy in patients with hypertriglyceridemia and low high density lipoprotein (HDL)-cholesterol: greater reduction of non-HDL cholesterol in subjects with excess body weight (The CIPROAMLAT study). Cardiovasc Diabetol (2004) 0.75

Atropine for exercise testing after acute myocardial infarction. Int J Cardiovasc Imaging (2005) 0.75

Multidetector computed tomography of a giant left mainstem aneurysm. Eur Heart J Cardiovasc Imaging (2011) 0.75

[Myocardial perfusion scintigraphy. Exact and cost-effective coronary disease imaging--secondary publication]. Ugeskr Laeger (2008) 0.75